ROCKVILLE, Md., Nov. 17, 2010 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (NYSE Amex:GTF), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that Peter A. Clausen, Ph.D., Vice President of Technology and Business Development at Cytomedix, will deliver a podium presentation of data underlying the scientific and clinical rationale for the use of the Company's AutoloGel™ System to effect rapid healing of chronic wounds at the Desert Foot Conference 2010: the 7th Annual High Risk Diabetic Foot Conference being held from November 17—19, 2010 at the Fairmont Scottsdale in Scottsdale, Arizona.
